Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma
Abstract Comprehensive analysis of clinical samples has recently identified molecular and immunological classification of hepatocellular carcinoma (HCC), and the CTNNB1 (β-catenin)-mutated subtype exhibits distinctive characteristics of immunosuppressive tumor microenvironment. For clarifying the mo...
Saved in:
Main Authors: | Masafumi Akasu, Shu Shimada, Ayano Kabashima, Yoshimitsu Akiyama, Masahiro Shimokawa, Keiichi Akahoshi, Atsushi Kudo, Shoji Yamaoka, Minoru Tanabe, Shinji Tanaka |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/63c7a6b15ee74a9d819e44b8f20fa851 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa
by: Franciscus C. Vermeer, et al.
Published: (2021) -
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5
by: Tomohiko Yamamura, et al.
Published: (2020) -
Machine learning based CRISPR gRNA design for therapeutic exon skipping.
by: Wilson Louie, et al.
Published: (2021) -
Hexose enhances oligonucleotide delivery and exon skipping in dystrophin-deficient mdx mice
by: Gang Han, et al.
Published: (2016) -
Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapy
by: Pablo Beckers, et al.
Published: (2021)